Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alector (ALEC) Cash & Equivalents (2018 - 2026)

Alector has reported Cash & Equivalents over the past 8 years, most recently at $65.8 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 99.27% to $65.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.8 million through Dec 2025, up 99.27% year-over-year, with the annual reading at $65.8 million for FY2025, 99.27% up from the prior year.
  • Cash & Equivalents was $65.8 million for Q4 2025 at Alector, down from $76.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $516.5 million in Q3 2021 and troughed at $33.0 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $106.3 million (2021), against an average of $148.3 million.
  • Year-over-year, Cash & Equivalents surged 558.71% in 2021 and then tumbled 64.33% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $329.2 million in 2021, then plummeted by 53.11% to $154.3 million in 2022, then plummeted by 51.69% to $74.6 million in 2023, then plummeted by 55.71% to $33.0 million in 2024, then soared by 99.27% to $65.8 million in 2025.
  • Per Business Quant, the three most recent readings for ALEC's Cash & Equivalents are $65.8 million (Q4 2025), $76.5 million (Q3 2025), and $44.8 million (Q2 2025).